Mex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mex

Property Description
Active ingredient Cefuroxime
Forms Tablet, oral suspension, powder for injection
Pharmacological Class Second-Generation Cephalosporin, beta-Lactam Antibiotic
General Purpose Systemic bacterial infection elimination
Origin Semisynthetic

Mex: Definition, Active Ingredient, and Core Classification

The medicine Mex is a pharmaceutical product containing the active substance Cefuroxime, which functions as a semisynthetic beta-Lactam antibiotic. Cefuroxime is fundamentally classified as a second-generation cephalosporin, belonging to a major class of powerful anti-infective agents. As a systemic antibacterial agent, it is used to treat bacterial diseases. This classification is clinically recognized for providing enhanced stability against certain bacterial defense mechanisms compared to earlier cephalosporins.


Cefuroxime is not a naturally occurring compound but is semisynthetic, derived from the naturally sourced Cephalosporin C nucleus and subsequently modified to enhance its therapeutic stability and effectiveness against a broader range of bacterial pathogens. This modification places it within the large beta-Lactam family, yet its position as a second-generation agent grants it a significantly broad-spectrum capability, surpassing the scope of activity typically seen in older antibiotics. The primary purpose of Cefuroxime is to provide a robust, systematic means for destroying various disease-causing bacteria throughout the body.

The Forms of Cefuroxime and Its General Antibacterial Purpose

Cefuroxime is manufactured in various dosage forms to accommodate different patient needs and administration routes, primarily including the film-coated tablet or oral suspension for consumption by mouth, and a powder for solution used to prepare intravenous or intramuscular injections. This dual availability in both oral and injectable forms makes it highly versatile, allowing for the continuity of care.


The difference in preparation relates directly to the chemical form of the active ingredient: for oral use, the substance is often present as the Cefuroxime axetil prodrug, which is efficiently absorbed by the digestive system before becoming fully active. For direct systemic administration (injection), the compound used is typically Cefuroxime sodium. As a bactericidal agent, Cefuroxime's general purpose is to achieve the swift and final elimination of pathogenic bacteria by disrupting the synthesis of their cell wall, providing a comprehensive solution against systemic bacterial infections, such as those that affect the respiratory tract.

Regulatory References

  1. NIH: Cefuroxime Overview

What side effects are possible with Mex?

Possible Side Effects and Safety Information

Mex (Cefuroxime), a second-generation cephalosporin antibiotic, has a regulatory safety profile defined by officially documented adverse reactions classified by frequency and affected body system. The most Common adverse reactions, as established in regulatory documents, include gastrointestinal issues such as diarrhea, nausea, and vomiting, alongside nervous system effects like headache and dizziness. Effects on the blood system, such as eosinophilia and neutropenia, are also classified as Common.


Uncommon effects listed in the safety data include changes in blood cell counts, such as leukopenia and a positive Coombs’ test, and mild skin reactions like rash and pruritus.

Serious Adverse Reactions and Safety Constraints

Official regulatory labeling includes documentation of rare, but clinically significant, adverse reactions. These serious reactions include severe systemic hypersensitivity events such as anaphylaxis, severe cutaneous reactions like Stevens-Johnson syndrome (SJS), and potentially fatal Clostridioides difficile-associated diarrhea (CDAD), which may occur during or up to two months after treatment. Neurological complications, including seizures and encephalopathy, are also documented, particularly when the drug is used in patients with pre-existing renal impairment without appropriate clearance consideration.


Safety constraints noted in official prescribing information include the risk of superinfection from non-susceptible organisms, such as Candida. Furthermore, the oral suspension formulation contains phenylalanine, a constraint explicitly noted for individuals with phenylketonuria (PKU).

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information for Mex (Cefuroxime)

Official regulatory documentation details the documented manifestations and required emergency actions in the event of a Cefuroxime overdose.


Documented Overdose Scope

Feature Regulatory Documentation Statement
Documented Overdose Presentations Symptoms include cerebral irritation, convulsions (seizures), encephalopathy, and coma.
Physiological Systems Affected Primarily the Central Nervous System (CNS).
Population-specific Overdose Notes Symptoms are more likely if the dose is not reduced appropriately in patients with renal impairment.

Emergency Response and Management

Feature Regulatory Documentation Statement
When immediate help is required Immediately upon suspicion of an overdose, even if there are no symptoms.
Emergency-response actions Contact a healthcare professional, hospital emergency department, or regional poison control center immediately.
Antidote Status No specific antidote exists for Cefuroxime overdose.
Supportive Management Treatment is symptomatic and supportive. Procedures like haemodialysis and peritoneal dialysis can reduce drug serum levels.

The official overdose profile emphasizes that Cefuroxime overdose may manifest through severe neurological sequelae, necessitating the mandate to seek immediate medical attention regardless of symptom presence. Since no specific antidote is known, the official management is defined by supportive procedures for managing the documented signs and symptoms.

Therapeutic Uses of Mex

Mex is primarily used to assist in the temporary relief of mild to moderate symptoms across various common health scenarios. This medication helps manage discomfort associated with acute conditions, including headache, minor injuries, dental pain, and fever. The therapeutic goal is to ease the symptomatic burden and support a better quality of life during periods of acute discomfort.

In addition to acute uses, Mex is also an available option for managing symptoms related to certain chronic inflammatory conditions. By helping to mitigate persistent swelling and stiffness, it supports improved physical comfort and daily function for individuals with conditions such as mild arthritis or muscle strains.


Quick Fact: Relief for Acute Discomfort and Inflammation-related Stiffness

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Mex?

This medication is officially contraindicated and must not be used in individuals with a known hypersensitivity or allergy to mexiletine, its components, or other local anesthetics of the amide-type (such as lidocaine).

Contraindicated Populations

Official regulatory documents define specific cardiac conditions that exclude use. The drug is contraindicated in patients presenting with cardiogenic shock or a pre-existing second- or third-degree atrioventricular (AV) block when a pacemaker is not present. Use is also prohibited in patients with severe hepatic impairment.

Age and Physiological Restrictions

The safety and effectiveness of this medicine in the pediatric population have not been established. For pregnant women, use is generally reserved for situations where the potential benefit justifies the potential risk. Due to its excretion in breast milk, lactating women are generally advised to discontinue breastfeeding or the medication.

Condition-Specific Limitations

Use is not recommended for patients with severe renal impairment. For those with mild or moderate hepatic impairment, the medicine must be used with caution and under close monitoring, reflecting specific limitations defined in official regulatory labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Cefuroxime (Mex) is defined by pharmacokinetic and pharmacodynamic interactions documented in government regulatory sources, which establish specific administration constraints.

Documented Interaction Patterns

Interacting Substance/Class Official Interaction Description
Probenecid Inhibits renal tubular secretion, resulting in increased peak serum concentrations and prolonged elimination half-life of Cefuroxime.
Gastric Acidity Reducers (e.g., Antacids, Cimetidine) Lower the bioavailability of the oral prodrug (Cefuroxime axetil), formally reducing serum concentrations.
Oral Anticoagulants Co-administration may give rise to increased International Normalized Ratio (INR).
Aminoglycosides / Potent Diuretics Reported potential for increased risk of renal impairment (nephrotoxicity).
Combined Oral Contraceptives May reduce the efficacy of the contraceptive by affecting gut flora and oestrogen reabsorption.
Bacteriostatic Antibiotics (e.g., Chloramphenicol) Avoid concurrent use due to potential interference with Cefuroxime's bactericidal action.

Administration and Timing Constraints

The absorption of the oral suspension form is required to be taken with meals as food significantly enhances absorption. A mandatory timing rule applies to Didanosine (chewable tablets/suspension), which must be administered two hours before or several hours after Cefuroxime. In patients with impaired renal function, slower elimination causes higher and prolonged serum concentrations, which is an interaction requiring modification of the dosing schedule.

Mechanism of Action

Mex (Cefuroxime) functions as an irreversible covalent inhibitor that targets Penicillin-Binding Proteins (PBPs), which are bacterial enzymes essential for cell wall synthesis. The drug molecule binds permanently to the active site of these PBPs, thereby immediately stopping the transpeptidation reaction, a critical step for cross-linking the peptidoglycan strands that provide the cell wall with rigidity. The cessation of cross-linking initiates a destructive physiological cascade: the resulting structural instability, compounded by the drug's influence in triggering the bacteria's own latent autolytic enzymes (autolysins), causes the cell wall to rapidly degrade. Unable to withstand the internal osmotic pressure, the bacterial cell swells and ruptures (lysis), achieving bactericidal activity. A key mechanistic characteristic is the molecule's enhanced chemical stability against many common bacterial beta-lactamase enzymes, which ensures the drug remains intact long enough to maintain the inhibition of PBP targets against resistant strains.

Dosage and Administration Information

How to Use Mex: Administration Guidelines

This section outlines instructions for the administration of Mex.

Administration Details

Feature Instruction
Route of Administration Oral, by swallowing the tablet whole.
Standard Dosing The recommended starting dose for adults is 15 mg taken once daily. The dose may be adjusted by a healthcare provider up to a maximum of 30 mg once daily, based on individual patient response.
Frequency and Timing Take once daily, at approximately the same time each day. May be taken with or without food.
Preparation No preparation steps are required. The tablet must be swallowed whole; do not crush, chew, or split it.
Age-Group Use Adults (18 years and older): Use as per the standard dosing schedule. Pediatric Patients (under 18): Use is generally not recommended as efficacy and safety have not been established.

Procedural and Missed-Dose Rules

Missed Dose Instructions:

  1. If a dose is missed, take it as soon as it is remembered.
  2. However, if it is close to the time of the next scheduled dose (e.g., less than 12 hours remaining until the next dose), skip the missed dose entirely.
  3. Resume the medication at the regular time with the next scheduled dose. Do not take two doses at the same time to compensate for a missed dose.

Procedural Summary: The medication must be swallowed intact with water, taken consistently once a day, regardless of meals. Dose adjustments are managed by a healthcare professional, within the range of 15 mg to 30 mg daily.

Recent Clinical Evidence

Research evidence / Overview of Studies for Mex (Cefuroxime)


Evidence for Common Bacterial Infections

Research has extensively explored Cefuroxime when studied for conditions involving bacterial infections in the respiratory tract, uncomplicated skin and soft tissue infections, and uncomplicated urinary tract infections (UTIs). The evidence comes primarily from short-term Randomized Controlled Trials (RCTs) and clinical comparisons. Studies examined outcomes related to clinical response, such as symptom resolution, and bacteriological eradication (measured pathogen status). For surgical use, large meta-analyses studied Cefuroxime as an antimicrobial prophylaxis (SAP), tracking the incidence of Surgical Site Infection (SSI) in surgical patients. Research also explored the drug in the early, localized form of Lyme Disease, where trials monitored the clinical resolution of the characteristic skin lesion. Comparative studies documented measurements of resolution criteria relative to other active treatments.


Studies in Special Patient Groups and Limitations

The research includes specific evaluations of Cefuroxime in pediatric patients for respiratory infections and in older adults assessing community-acquired pneumonia. Few data are available for outcomes related to pregnant individuals who were included in some studies for specific infections like pyelonephritis. Research focused on patients with other significant health issues is not as extensive as the data available for the general study population.


Long-Term Outcomes and Uncertainty

The majority of clinical trials focused on episodes where symptoms become more noticeable, resulting in follow-up durations that were limited to the short-term treatment phase. As a result, there is limited information that tracks the durability of the response or the recurrence of infection over many months. The regulatory research record highlights several areas where certainty remains low:

  • Subgroup findings are uncertain for many specialized populations beyond those explicitly included in initial pivotal trials.
  • Research is ongoing to address the clinical relevance of evolving bacterial resistance patterns for this class of antibiotics.
  • The comparative evidence is lacking for some of the newer therapeutic options now available.

Findings describe group patterns, not personal outcomes, meaning the research does not determine whether an individual will respond similarly.

How should Mex be stored and disposed of?

How to Store and Dispose of Cefuroxime

Official regulatory guidelines for Cefuroxime (Mex) storage and disposal depend on its specific form. All dosage forms must be kept out of the sight and reach of children.

Storage Requirements

Dosage Form Temperature & Protection Stability After Preparation
Tablets Store at room temperature, away from excess heat and moisture. N/A
Oral Suspension (Powder) Store below 30 C and protected from light. Reconstituted liquid must be refrigerated (2 C to 8 C) and discarded after 10 days.
Powder for Injection Store below 25 C in the original package, protected from light. The prepared solution must be used immediately or within 24 hours under refrigeration.

Disposal

Any unused or expired product must be disposed of in accordance with local official requirements. Do not discard medication into wastewater or household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mex found in:

A-Z Index: